Tuesday 19 May Yesterday I bought some shares in Rhinomed (RNO) at 5.2¢ and they finished the day at 4.5¢. Not good timing. I commented on the shares in another post today.
Friday 15 May Today I bought shares in Service Stream Ltd (SSM) at an average of 25.9¢. They had broken upwards yesterday from a multi-year downtrend AND from a 2 year bottom formation. Double click on the chart below to see more detail. SSM has 386m shares on issue and at yesterday’s closing price has a … Read more
Thursday 14 May I bought back into two stocks today, Capitol (CAJ) at 94.5¢ and Spookfish (SFI) at 6¢. I had sold them earlier in the year, CAJ at 94.5¢ (yes, at the same price) and SFI at 5.5¢, when they broke short term support. I feel that, technically, the risks are now reduced. I guess I … Read more
Wednesday 13 May I sold the holding in Actinogen (ACW) this morning as it had broken its uptrend yesterday. Unfortunately I only got 8.3¢ for them, way lower than yesterday’s close of 8.6¢, and they closed today at 8.4¢. I had bought them in January and February at an average price of 5.8¢ including brokerage, so it was a reasonable … Read more
Monday 11 May Today I bought shares in Talga Resources (TLG) at 47¢, thereby breaking my rule of only buying breakouts (TLG needs to break above 50¢ to qualify). But I do feel the story is a good one. TLG has 138.4 million shares on issue and 19.6 million options mostly with a strike of between 35¢ and … Read more
Thursday 7 May Yesterday I sold AZK at 29¢ and IWG at 32¢. I made the decision to sell AZK after the close of trade on Tuesday when they finished at 32¢. Unfortunately they opened lower on Wednesday so I could only get 29¢ for them. They finished today at 25¢. The realised price of 29¢ … Read more
Thursday 7 May On Monday 4 May I sold the holdings in MVP at $2.02 and SFI at 55¢ and bought ZIP at 66¢. MVP spooked me when it fell out of bed in April and I had been waiting for a rally from the low of $1.70 before selling. My average price was $1.78 back in … Read more
Friday 1 May Today I sold the holdings in EMH and CXB at 21.5¢ and 9.3¢, respectively, making a small gain on the combined total. I had purchased EMH at 22.5¢ and CBX at 8.5¢ earlier this week. My reasoning was that CBX broke support at 10¢, and since CBX’s and EMH’s fortunes are similar, … Read more
Thursday 30 April CXB finished today at 11.5¢, up 1.5¢ and now a reasonable margin above the 8.5¢ at which I bought them earlier in the week. On the daily chart I would have been relatively relaxed. However, looking at the intraday chart I see that during the day the stock hit a new high of … Read more
Thursday 30 April (This is what I wrote after the first transaction) Well, I had to bite the bullet today and sold half my holding at 24.5¢ at around 11am. Still a good profit on the purchase price of 4.7¢ but not as much as it could have been given that it peaked at 61.5¢ … Read more
Tuesday 28 April Today I sold the holding in Xero Ltd (XRO) and bought into Cobre Montana NL (CXB) at 8.5¢ and European Metals Holdings Ltd (EMH) at 22.5¢. I had purchased XRO back in March 2014 at $41.94, and sold them today at $20.10. It was the longest held holding in the portfolio and my … Read more
Tuesday 28 April The stock finished the day at 38.5¢, down 6.5¢. Earlier in the day it peaked at 62.5¢. Is this a (bearish signal) one day reversal? I don’t think so. Anyway it remains in uptrend. Am still holding.
Monday 27 April AZK rose a further 13.5¢ to 45¢ today, or between 9 and 10 times the 4.7¢ I paid just a few weeks ago. It remains in uptrend. Its theoretical market cap is now $331m, based on a potential total of 734.5 million shares on issue (this differs from my previous estimates of 705.8 million shares) comprising: … Read more
27 April 2015 ABX has 140.5 million shares on issue and at the current market price of 31¢ it has a market cap of some $44m. It has no debt. Its cash position was $4.7m at 31 December and the latest update (as at 19 March) was that it had a cash position of $3.5m. BX holds leases containing … Read more
Saturday 25 April AZK finished the week at 31.5¢ and remains in uptrend. Take no notice of ASX data on the number of shares issued. They disclose 208.3 million shares, whereas the potential is for the total to increase to 705.8 million shares when the Brainchip vendor shares and performance shares are issued. On that … Read more
Friday 24 April I sold the holding in GBT today at $6.11 due to yesterday’s break of the uptrend line. Not a bad profit – I had bought them in August last year at $4.20 and again in October at $3.79 for an average of $4.01.
Thursday 23 April On Tuesday I sold out of Aeris (AEI) at 41.5¢ on a break of the uptrend line. Couldn’t inform you until now because of internet connection problems. I bought the stock at 24¢ back in November so it wasn’t a bad profit.
Thursday 23 Apr I had been hoping with heart in my mouth that the stock would break upside from that consolidation pattern that had contained the stock for the past few days. Today it did just that! It finished at 26.5¢, up 8.5¢ or 47% on the day, making it up over 5 times my … Read more
Wednesday 15 April Yesterday I sold the position in PEH and bought into E88 and MBE. Shares of Pacific Environment Ltd (PEH) broke their short term uptrend line on Tuesday and under my trading system I had no choice but to sell. I achieved 10.5¢ which was a slight loss on my purchase price of 10.6¢ … Read more
AZK rose another 4.5¢ to 19.0¢, so have trebled my money in less than a month. Not often I get one like this! Will have to watch it like a hawk now,and sell as soon as the very steep uptrend line is broken.
AKP fell through a short term uptrend line a couple of days ago and recovered a little yesterday. The decision to sell, however, is clouded by the fact that it has not yet breached an alternative short term uptrend line. I will give it the benefit of the doubt at this point.
Yesterday CAJ fell 7¢ to 98¢ and in doing so it breached a short term uptrend line. The longer term uptrend is still in place but I believe the short term momentum has been lost and that the shares could drift back to the 75-80¢ level. I made the decision last night to sell and I … Read more
Capitol Health provides diagnostic medical imaging services to radiology practices. Until recently it was entirely Victorian based but in March 2015 it expanded into NSW with the $64.6m purchase of Southern Radiology in Sydney. This followed hard on the heels of a similar $25m acquisition in Melbourne. These acquisitions together had achieved revenues of $47.4m and EBITDA of $10.5m … Read more
Sold the position in AMA today, at 54¢. The price has stalled in the last week or so but the chart has not broken down at this point. However I needed the money.
Aziana’s suspension was lifted today after an announcement that due diligence on Brinchip was successfully concluded and that the option to purchase has been exercised. So it was good news, not bad news as I had feared. The shares shot up to a new high of 14.5¢ so now I have trebled my money in a matter … Read more
ARU (Arafura Resources) 6.5¢ Smarttrans (SMA) 2.2¢ St Barbara (SBM) 27¢
Medical Developments International Ltd (ASX:MVP) is a small but well established and profitable biotech company. Its main product is Penthrox, a fast onset, non-opioid analgesic indicated for pain relief, self-administered via an inhaler by conscious patients with trauma and those requiring analgesia for surgical procedures. It is much superior to rival products such as Panadol 4 or … Read more
Alzheimer’s is the only one among the top ten causes of death in America that cannot be prevented, cured or even slowed. One in three elderly persons dies with Alzheimer’s or another dementia. Actinogen (ASX:ACW) is developing a novel treatment for Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI). Its drug Xanamem blocks production in the brain of … Read more
Here is my current portfolio of Chart Investments (chosen primarily for chart breakouts). I have reviewed some of them in the blog over the last couple of weeks and will tackle the others over time. Very few have been held more than a year, and the number of stocks sold so far this year is 44, twice as many … Read more
Pro Medicus (ASX:PME) is a profitable and fast growing software developer within the healthcare industry, providing radiology information systems and practice management software to radiologist practices and hospitals. It has operations in Australia, Europe and more recently in the USA. Its greatest growth potential is in the USA. With 100.3m shares outstanding, the current share price of $1.58 … Read more